Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade.

Samson A, Scott KJ, Taggart D, West EJ, Wilson E, Nuovo GJ, Thomson S, Corns R, Mathew RK, Fuller MJ, Kottke TJ, Thompson JM, Ilett EJ, Cockle JV, van Hille P, Sivakumar G, Polson ES, Turnbull SJ, Appleton ES, Migneco G, Rose AS, Coffey MC, Beirne DA, Collinson FJ, Ralph C, Alan Anthoney D, Twelves CJ, Furness AJ, Quezada SA, Wurdak H, Errington-Mais F, Pandha H, Harrington KJ, Selby PJ, Vile RG, Griffin SD, Stead LF, Short SC, Melcher AA.

Sci Transl Med. 2018 Jan 3;10(422). pii: eaam7577. doi: 10.1126/scitranslmed.aam7577.

2.

Oncolytic reovirus enhances rituximab-mediated antibody-dependent cellular cytotoxicity against chronic lymphocytic leukaemia.

Parrish C, Scott GB, Migneco G, Scott KJ, Steele LP, Ilett E, West EJ, Hall K, Selby PJ, Buchanan D, Varghese A, Cragg MS, Coffey M, Hillmen P, Melcher AA, Errington-Mais F.

Leukemia. 2015 Sep;29(9):1799-810. doi: 10.1038/leu.2015.88. Epub 2015 Mar 27.

3.

The autophagic tumor stroma model of cancer or "battery-operated tumor growth": A simple solution to the autophagy paradox.

Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, Tsirigos A, Migneco G, Witkiewicz A, Balliet R, Mercier I, Wang C, Flomenberg N, Howell A, Lin Z, Caro J, Pestell RG, Sotgia F, Lisanti MP.

Cell Cycle. 2010 Nov 1;9(21):4297-306. Epub 2010 Nov 30. Review.

4.

HIF1-alpha functions as a tumor promoter in cancer associated fibroblasts, and as a tumor suppressor in breast cancer cells: Autophagy drives compartment-specific oncogenesis.

Chiavarina B, Whitaker-Menezes D, Migneco G, Martinez-Outschoorn UE, Pavlides S, Howell A, Tanowitz HB, Casimiro MC, Wang C, Pestell RG, Grieshaber P, Caro J, Sotgia F, Lisanti MP.

Cell Cycle. 2010 Sep 1;9(17):3534-51. Epub 2010 Sep 4.

5.

The autophagic tumor stroma model of cancer: Role of oxidative stress and ketone production in fueling tumor cell metabolism.

Pavlides S, Tsirigos A, Migneco G, Whitaker-Menezes D, Chiavarina B, Flomenberg N, Frank PG, Casimiro MC, Wang C, Pestell RG, Martinez-Outschoorn UE, Howell A, Sotgia F, Lisanti MP.

Cell Cycle. 2010 Sep 1;9(17):3485-505. doi: 10.4161/cc.9.17.12721.

6.

Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.

Migneco G, Whitaker-Menezes D, Chiavarina B, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Flomenberg N, Tsirigos A, Howell A, Martinez-Outschoorn UE, Sotgia F, Lisanti MP.

Cell Cycle. 2010 Jun 15;9(12):2412-22. Epub 2010 Jun 15.

PMID:
20562527
7.

Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: implications for breast cancer and DCIS therapy with autophagy inhibitors.

Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Daumer KM, Milliman JN, Chiavarina B, Migneco G, Witkiewicz AK, Martinez-Cantarin MP, Flomenberg N, Howell A, Pestell RG, Lisanti MP, Sotgia F.

Cell Cycle. 2010 Jun 15;9(12):2423-33. Epub 2010 Jun 15.

PMID:
20562526
8.

The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.

Bonuccelli G, Whitaker-Menezes D, Castello-Cros R, Pavlides S, Pestell RG, Fatatis A, Witkiewicz AK, Vander Heiden MG, Migneco G, Chiavarina B, Frank PG, Capozza F, Flomenberg N, Martinez-Outschoorn UE, Sotgia F, Lisanti MP.

Cell Cycle. 2010 May 15;9(10):1960-71. Epub 2010 May 15.

PMID:
20495363
9.

[Factors predicting the response to alpha-interferon therapy in patients with chronic hepatitis C].

Soresi M, Tripi S, Cartabellotta A, di Gaetano G, Carroccio A, Amato S, Migneco G, Montalto G.

Recenti Prog Med. 1996 Apr;87(4):154-7. Italian.

PMID:
8643875
10.

Serum Levels of Soluble IL-2R, CD4 and CD8 in Chronic Active HCV Positive Hepatitis.

Caruso C, Candore G, Cigna D, Tripi S, Di Gaetano G, Migneco G, Montalto G, Ruggieri I, Notarbartolo A.

Mediators Inflamm. 1994;3(3):185-7.

11.

[Serum zinc concentration and antibody response to hepatitis B vaccine in hemodialysis patients].

Migneco G, Tripi S, Navetta A, La Ferla A, Vaccaro F.

Minerva Med. 1990 Jan-Feb;81(1-2):19-21. Italian.

PMID:
2138258
12.

[Maternal-fetal transmission of infection with hepatitis B virus: evaluation of viral markers in maternal and fetal biological materials and relation with the vaccine response].

Damiani S, Attanasio P, Maneschi F, Speciale P, La Ferla A, Navetta A, Tripi S, Migneco G.

Ann Ostet Ginecol Med Perinat. 1989 Sep-Oct;110(5):217-25. Italian.

PMID:
2534523
13.

[Can thymostimulin influence the course of malignant subacute hepatitis?].

Tripi S, Migneco G, Mascarella A, Di Marco P, La Cascia C, Citarrella P.

Clin Ter. 1987 Oct 31;123(2):133-7. Italian. No abstract available.

PMID:
2972474
14.
15.

[Infection with the hepatitis B virus (HBV), the human T-lymphotropic retrovirus (HIV) and Treponema pallidum in jailed minors].

Migneco G, Valentino L, Navetta A, Lampiasi AM, Bagnasco D, Lupo G.

Boll Soc Ital Biol Sper. 1987 Mar 31;63(3):241-5. Italian. No abstract available.

PMID:
3307838
16.

HBV infection risk in hospital workers.

Migneco G, Valentino L, Tripi S, Portera M, La Cascia C, Dardanoni G, Navetta A, Dardanoni L.

Boll Ist Sieroter Milan. 1987;66(1):18-22.

PMID:
3620120
17.

Prevalence of hepatitis B virus infection in chronic users of hepatotoxic drugs and alcoholic cirrhotic patients.

Migneco G, Mascarella A, Tripi S, La Cascia C, Cusimano R, Vigneri S, Attianese R, Scialabba A.

Boll Ist Sieroter Milan. 1987;66(3):181-4.

PMID:
3435649
18.

[Hepatitis B virus infection in habitual sexual partners].

Migneco G, Valentino L, Tripi S, Maneschi F, La Cascia C, Navetta A, Bagnasco D.

Boll Ist Sieroter Milan. 1987;66(3):175-80. Italian.

PMID:
3435648
19.

Peripheral nerve involvement in chronic liver disease. Clinical and electrophysiological study.

Fierro B, Raimondo D, Castiglione MG, Migneco G, Scoppa F, Savettieri G.

Ital J Neurol Sci. 1986 Dec;7(6):589-90.

PMID:
3026997
20.

[HBV, HDV and HTLV-III infections in drug addicts, cirrhotics and hemodialysis patients].

Migneco G, Attianese R, La Cascia C, Miceli DM, Tripi S, Mascarella A, Milano S.

Boll Soc Ital Biol Sper. 1986 Oct 30;62(10):1305-10. Italian. No abstract available.

PMID:
3828128
21.

[Cytolytic episodes during cirrhosis].

Migneco G, Mascarella A, Tripi S, La Cascia C, Navetta A.

Clin Ter. 1986 Jul 31;118(2):93-8. Italian. No abstract available.

PMID:
2874912
22.

[Clofibrate hepatitis. A case report].

Migneco G, Mascarella A, La Ferla A, Attianese R.

Minerva Med. 1986 May 7;77(19):799-800. Italian.

PMID:
3714094
23.

Platelet thromboxane production in liver cirrhosis.

Davì G, Migneco G, Vigneri S, Tripi S, Scialabba A, Strano A.

Prostaglandins Leukot Med. 1985 Jul;19(1):99-104.

PMID:
3862139
24.

[Serum monoamine oxidase (MAO) in the differential diagnosis of chronic liver disease. I].

Averna MR, Genova G, Montalto G, Labisi M, Mazza G, Migneco G, Tripi S, Notarbartolo A.

Boll Soc Ital Biol Sper. 1984 Sep 30;60(9):1671-7. Italian.

PMID:
6525286
25.

[Observations on a case of liver cirrhosis in its terminal phase].

Migneco G, Mascarella A, Tripi S, La Cascia C, Di Caro R.

Clin Ter. 1984 Sep 30;110(6):587-9. Italian. No abstract available.

PMID:
6238772
26.

[Serum monoamine oxidase (MAO) as a prognostic indicator in chronic active hepatitis. II].

Averna MR, Genova G, Montalto G, Rini GB, Marino G, Migneco G, La Cascia C, Notarbartolo A.

Boll Soc Ital Biol Sper. 1984 Sep 30;60(9):1679-84. Italian.

PMID:
6084514
27.

[Etiopathogenetic considerations on a case record of cirrhotic patients from western Sicily].

Migneco G, Chiarini A, Tripi S, Arista S, La Cascia C, Mascarella A, Di Trapani A.

Boll Ist Sieroter Milan. 1984 Sep;63(4):308-18. Italian.

PMID:
6097289
28.

Malignancies and false-positive serological results for hydatidosis.

Mansueto S, Migneco G, La Cascia C, Miceli MD.

Br Med J. 1980 Nov 8;281(6250):1284. No abstract available.

29.

Simplified counter-immunoelectrophoresis (CIEP) with a commercially produced antigen on cellulose acetate membrane for the diagnosis of hydatidosis.

Mansueto S, Migneco G, Tripi S, Picone DM.

Trans R Soc Trop Med Hyg. 1980;74(2):260-1. No abstract available.

PMID:
7385305
30.

[Sporadic persistence of amebic hepatitis].

Mansueto S, Migneco G.

Minerva Med. 1979 Sep 15;70(38):2641-9. Italian.

PMID:
481789
31.
32.

[Counterimmunoelectrophoresis on cellulose acetate membrane with a commercial lyophilized antigen in diagnosis of human hydatidosis].

Mansueto S, Migneco G, Tripi S, Picone D, Miceli D.

Boll Ist Sieroter Milan. 1979 Jul 31;58(3):260-5. Italian.

PMID:
92994
33.

[Summary of the epidemiology of dermotyphous rickettsiosis in Sicily until the 1960's].

Migneco G.

Minerva Med. 1977 Jul 14;68(34):2353-6. Italian. No abstract available.

PMID:
887212
34.

[The complement fixation test with BCG in the diagnosis of leishmaniasis].

Mansueto S, Migneco G, La Cascia C.

Boll Ist Sieroter Milan. 1975 Jun 26;54(2):140-4. Italian.

PMID:
54183
35.

[Comparison between fixation test with BCG and immunofluorescence in the diagnosis of leishmaniasis].

Mansueto S, Migneco G, Didato A.

Ann Sclavo. 1975 May-Jun;17(3):275-82. Italian.

PMID:
779671
36.

[BCG in the diagnosis of leishmaniasis. Comparison of the complement fixation test and latex agglutination test].

Mansueto S, Migneco G, La Cascia C.

Boll Soc Ital Biol Sper. 1974 Nov 15;50(21):1758-64. Italian. No abstract available.

PMID:
4618482
37.

[Epidemiology of cholera in relation to modern methods of transport].

Mansueto S, Migneco G.

Minerva Med. 1974 Nov 14;65(81):4227-37. Italian. No abstract available.

PMID:
4431578
38.

[Behavior of Australia antigen (HB Ag) in patients with chronic hepatitis before and after corticosteroid therapy].

Migneco G, Tripi S, Didato A.

Boll Soc Ital Biol Sper. 1974 Aug 30;50(13):976-8. Italian. No abstract available.

PMID:
4463988
39.

[Feto-specific alpha-1 serum protein. Significance of its finding in the blood and personal experiences].

Migneco G, Didato A, Tripi S.

Ann Sclavo. 1974 May-Jun;16(3):315-24. Italian. No abstract available.

PMID:
4139933
40.

[Detection of Australia antigen (HB.Ag) in patients with chronic hepatitis and cirrhosis].

Migneco G, Tripi S, Didato A.

Boll Soc Ital Biol Sper. 1974 Apr 15;50(7):466-8. Italian. No abstract available.

PMID:
4441444
44.

[Australia antigen in various liver diseases (except acute hepatitis). 3].

Migneco G, Mansueto S, Tripi S.

G Mal Infett Parassit. 1971 Dec;23(12):1125-6. Italian. No abstract available.

PMID:
5151318
45.

[Australia antigen in families of the hepatitis patients and in other subjects exposed to the possibility of contact with hepatitis. II].

Migneco G, Mansueto S, Tedesco V.

G Mal Infett Parassit. 1971 Dec;23(12):1111-5. Italian. No abstract available.

PMID:
5151316
46.

[Australia antigen in the course of acute hepatitis in our experience. I].

Migneco G, Mansueto S, Tedesco V.

G Mal Infett Parassit. 1971 Dec;23(12):1103-9. Italian. No abstract available.

PMID:
5151315
47.

[Australia antigen and viral hepatitis. Epidemiological study in blood donors].

Mansueto S, Tedesco V, Migneco G.

G Mal Infett Parassit. 1971 Dec;23(12):1137-40. Italian. No abstract available.

PMID:
5004898
48.

[On the distribution of the Australia antigen in normal population samples].

Migneco G, Mansueto S.

Boll Soc Ital Biol Sper. 1971 May 30;47(10):283-5. Italian. No abstract available.

PMID:
5110167
49.

[Chronology of increases of serum enzyme activities of cytoplasmic, mitochondrial and lysosome origin in viral hepatitis].

Giglio F, Pagliaro L, Le Moli S, Notarbartolo A, Migneco G.

Boll Soc Ital Biol Sper. 1966 Sep 30;42(18):1253-6. Italian. No abstract available.

PMID:
5971159
50.

[NADPH cytochrome c reductase activity of the cirrhotic human liver].

Giglio F, Notarbartolo A, Pagliaro L, Le Moli S, Migneco G.

Boll Soc Ital Biol Sper. 1966 Apr 15;42(7):340-3. Italian. No abstract available.

PMID:
5940218

Supplemental Content

Loading ...
Support Center